BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Kidney
,
Anticancer prodrugs
,
Fluoxetine
,
rs2230926
,
ZBTB7A
,
T cell differentiation
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Neurogenic differentiation factor 2
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
Fetal brain
Cerebellum
Cerebellar vermis
Hippocampus
Cerebellum peduncles
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Spotted fevers
Eczema
Lichen
Psoriasis
Skin lesion
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
minaprine
Megestrol Acetate
Dinitrophenols
Alprazolam
hexadecylpyridinium bromide
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
Mir30b
MIRLET7D
CHMP2B
PCSK7
SMARCC2
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
OMIM - Developmental and Epileptic Encephalopathy Disorders
Skin biopsies of psoriasis patients Itolizumab treated non-responders and responders
Sleep deprivation effects on gene expression in seven different regions of the brain
Liver Pharmacology and Xenobiotic Response Repertoire
Uterine endometrial stromal cells circadian gene expression during pregnancy
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for Neurogenic differentiation factor 2
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Changes of microRNA Expression in Obstructive and Neurogenic Bladder Dysfunction
Psychogenic and Neurogenic Components in Patients With Psychogenic or Neuropathic Pruritus
Cyclooxygenase-2 (COX-2) Inhibitor Reduces Serum Prostatic Specific Antigen (PSA) Levels
A Clinical Investigation Evaluating PeristeenĀ® Performance
Overactive Bladder Syndrome: Incobotulinumtoxin Versus Onabotulinumtoxin
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ